Mitinab 400 mg Tablet

Get a Price/Quote

MOQ : 200 Bottles

Mitinab 400 mg Tablet Specification

Origin of Medicine
INDIA

Physical Form
Tablets

Recommended For
DOCTOR

Quantity
200 Boxes

Route of Administration
Oral

Color
Light yellow

Shape
Oval

Therapeutic Category
Oncology

Tablet Marking
400

Shelf Life
24 months

Prescription Required
Yes

Blister Pack
Yes

Mitinab 400 mg Tablet Trade Information

Minimum Order Quantity
200 Bottles

Delivery Time
1 Week

About Mitinab 400 mg Tablet

Mitinab 400 mg Tablet is a targeted anticancer medication primarily used for the treatment of specific forms of leukemia and various blood cell disorders, as well as gastrointestinal stromal tumors (GISTs), which are tumors that develop in the digestive tract walls and may metastasize. This powerful drug works by inhibiting certain proteins that promote cancer cell growth, thereby helping to halt the progression of the disease. Additionally, Mitinab is effective in managing protuberant tumors that are inoperable, have spread, or recurred post-surgery, offering hope to patients facing challenging treatment scenarios. While it provides significant benefits, it's crucial to be aware of potential side effects, such as fluid retention, liver issues, and blood disorders, which require monitoring by a healthcare professional. Patients should discuss their complete medical history and any existing conditions with their doctor before starting treatment. Mitinab 400 mg Tablet represents a vital option in modern oncology, providing targeted therapy that can improve outcomes for those battling complex cancers. Always adhere to your healthcare providers recommendations for dosage and usage to ensure optimal effectiveness and safety.

Proven Oncology Solution

Mitinab 400 mg Tablet is formulated for the treatment of specific cancers under medical supervision, providing therapeutic benefits that are trusted by healthcare professionals. Manufactured in India and packaged meticulously, it delivers consistent quality and efficacy, making it a preferred choice for oncology patients worldwide.

Reliable Shelf Life and Packaging

This tablet maintains its stability and therapeutic potency for up to 24 months. Supplied in secure blister packs, Mitinab guarantees protection from moisture and contamination, contributing to both convenience for distributors and assurance for patients.

FAQ's of Mitinab 400 mg Tablet:

Q: How should Mitinab 400 mg Tablet be administered for optimal results?

A: Mitinab 400 mg Tablet is designed for oral administration and should be taken as prescribed by a healthcare professional to ensure maximum therapeutic efficacy in cancer treatment.

Q: What are the distinguishing features of Mitinab 400 mg Tablet?

A: Mitinab 400 mg Tablet is light yellow, oval-shaped, and marked with '400'. It is supplied in blister packs, produced in India, and specifically intended for oncology use.

Q: When does Mitinab 400 mg Tablet require a prescription?

A: Mitinab 400 mg Tablet is strictly prescription-only. It must be prescribed by a qualified doctor prior to administration, ensuring safe and compliant use.

Q: Where can distributors and suppliers source Mitinab 400 mg Tablet?

A: Mitinab 400 mg Tablet can be sourced from authorized distributors, exporters, suppliers, traders, and wholesalers based in India, strictly adhering to regulatory guidelines.

Q: What is the shelf life and recommended storage condition for Mitinab 400 mg Tablet?

A: Mitinab 400 mg Tablet has a shelf life of 24 months and should be stored in its original blister packaging, away from excessive moisture and light to maintain quality.

Q: How does the process of procuring and exporting Mitinab 400 mg Tablet work?

A: Interested parties must comply with export regulations and provide a valid prescription. They can place orders for the recommended quantity (200 boxes) through registered wholesale and distribution channels in India.

Q: What is the primary benefit of using Mitinab 400 mg Tablet in oncology treatment?

A: Mitinab 400 mg Tablet offers targeted therapeutic action in cancer therapy, backed by stringent quality standards and efficacy, supporting doctors and healthcare providers in improving patient outcomes.

Tell us about your requirement